Says treatment consists of Aspirin
Then points out that NSAIDs and steroids are contraindicated...checked some sources and it points out NSAIDs/Aspirin are treatment of choice. Steroids are not first line, however, if unsuccessful with the NSAIDs steroids may be used. Anyone else agree what they wrote is misleading/wrong?
Sorry...its on page 12
As you and others have already said, in general, mainstays for pericarditis are NSAIDs or aspirin. Corticosteroids should only be used if NSAIDs/aspirin don't work. So, I would change point a under number 5 on page 12 to read that "Treatment consists of aspirin or NSAIDs." For point b, cross out "NSAIDs and", and add "unless aspirin/NSAIDs fail to work" at the end of the sentence.
BiologyBY said:
Here is another one, under Crohn's disease, in section D it mentions pseudopolyps. These are seen in ulcerative colitis, not Crohn's
This is on p. 153 in
section C, number 1 if anyone is looking for it.
Actually, both Crohn's and UC can have pseudopolyps, so I'd leave that one alone. If you have big Robbins, look at table 17-10 on p. 851. Colonic Crohn's disease has "marked" pseudopolyps (as does UC), and even small intestinal Crohn's can have "slight" pseudopolyps. Maybe we should add the caveat on p. 153, section C, number 1 that pseudopolyps mainly occur in colonic Crohn's.
PenguinHead said:
Pg 300 Under Hormonal Control, point 2. Calcitonin, should be: "Kidney - decreased Ca++ reabsorption and decreased PO4 reabsorption.
Also, under 3. Vitamin D, should be "increased Ca++ and increased PO4 reabsorption."
The only thing I'd add to this is to specify that Penguin's second point (for vitamin D) is also referring specifically to the kidney, not to vitamin D in general, which is already correct as written.
So, for section 2 (calcitonin) point b (kidney), both calcium and phosphate reabsorption should be decreased. For section 3 (vitamin D) point b (kidney), both calcium and phosphate reabsorption should be increased.
Ok, and I found one more. This is a minor error, but it might as well be corrected while we're at it. On p. 332, Hemophilia A section, part A (general characteristics), number 1, the part in parentheses should read "approximately 1/10,000 male patients", *not* 1/1000. (On a side note, some sources reported the incidence of hemophilia A to be 1/10,000-1/5000, but never as high as 1/1000.)
At some point, I'll update the master list once more. Thanks again to everyone for contributing. You've done a heck of a job.